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Abstract
A common cause of pathological nystagmus is malfunction of the mechanism by which the brain integrates eye velocity signals
to produce eye position commands. For horizontal gaze, neurons in the nucleus prepositus hypoglossi-medial vestibular nucleus
region (NPH-MVN) play a vital role in this neural integrator function. We studied the effects on gaze stability of pharmacological
intervention in the NPH-MVN of monkeys by microinjections of eight drugs. Agents with agonist or antagonist actions at
gamma-aminobutyric acid (GABA), glutamate, and kainate receptors all caused gaze-evoked nystagmus with centripetal eye
drifts; glycine and strychnine had no effect. When the GABAA-agonist muscimol was injected near the center of MVN, the eyes
drifted away from the central position with increasing-velocity waveforms, implying an unstable neural integrator. The observed
effects of these drugs on gaze stability may be related to inactivation either of neurons within NPH-MVN or the cerebellar
projections to them that control the fidelity of neural integration. Drugs that influence GABA or glutamine transmission may have
a role in the treatment of nystagmus due to an abnormal neural integrator. Published by Elsevier Science Ltd.
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1. Introduction
For a clear and stable view of the world, images must
be held steadily on the retina, and the fovea must be
pointed at the object of interest (Carpenter, 1991). In
order to view clearly an object located off to one side,
each eye must be held at an eccentric position in the
orbit. The latter requires a tonic contraction of the
extraocular muscles to oppose the elastic forces im-
posed by the orbital tissues, which act to return the eye
to a central position (Leigh & Zee, 1999). To achieve
this sustained muscle contraction, the ocular motoneu-
rons must encode commands that have an eye position
component to them. Electrophysiological studies
confirm that the ocular motoneurons do modulate their
discharge rate with eye position — and also with
velocity during movements (Fuchs, Scudder & Kaneko,
1988). However, premotor neurons that send vestibular
(Waespe & Henn, 1977), saccadic (Van Gisbergen,
Robinson & Gielen, 1981), and pursuit signals (Miles &
Fuller, 1975) to the ocular motoneurons modulate their
discharge with eye velocity, not position. This differ-
ence implies that an integration of velocity-coded to
position-coded signals is achieved by the nervous sys-
tem (Robinson, 1975; Arnold & Robinson, 1997). It is
now established that, for horizontal eye movements,
this neural integration depends heavily upon the nu-
cleus prepositus hypoglossi-medial vestibular nucleus
region (NPH-MVN) in the caudal pons and medulla
(Cannon & Robinson, 1987; Cheron & Godaux, 1987);
for vertical eye movements, the interstitial nucleus of
Cajal plays a key role (Helmchen, Rambold, Fuhry &
Bu¨ttner, 1998). In addition, the cerebellum, especially
the flocculus, makes an important contribution (Car-
penter, 1972; Robinson, 1974; Zee, Yamazaki, Butler &
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Gu¨cer, 1981). Thus, lesions of any of these structures
impair the ability to hold the eyes in eccentric gaze;
they drift back towards the center of the orbits, and
corrective quick phases cause gaze-evoked nystagmus
— perhaps the commonest form of pathological nys-
tagmus (Leigh & Zee, 1999).
Recently, attempts have been made to understand
what neurotransmitters may be involved in the process
of neural integration, using the technique of pharmaco-
logical inactivation. Such knowledge is directly relevant
to understanding and treating pathological nystagmus
which interferes with clear vision. In the cat, microin-
jection of the GABAA-agonist muscimol into NPH-
MVN abolishes neural integration for horizontal
movements, so that the centripetal drift of the eyes after
a saccade is determined by the elastic pull of the orbit
tissues (Mettens, Godaux, Cheron & Galiana, 1994a).
Similar results are reported after muscimol injections
into the MVN of monkeys (Straube, Kurzan & Bu¨ttner,
1991). However, other neurotransmitters are reported
to contribute to normal function of the neural integra-
tor (Mettens, Cheron & Godaux, 1994b). One goal of
the present study was to compare the effects of agonist
and antagonist agents acting at GABAA, glutamate,
kainate, and glycine receptors.
2. Methods
2.1. Preparation of animals
All animal experiments were conducted in strict ac-
cordance with principles of laboratory animal care
(NIH publication No. 86-23, revised 1985). Three juve-
nile rhesus monkeys, Macaca mulatta, weighing be-
tween 2.5 and 4 kg, were used in this study. Each
monkey underwent two operations performed under
pentobarbital anesthesia and aseptic conditions. In the
first, a coil of wire was implanted in one eye, as
previously described (Arnold & Robinson, 1997), to
measure eye movements. One week later the animal was
trained to fixate dots back-projected on a screen by a
laser under the control of an x–y mirror galvanometer.
The monkeys were deprived of water for 1 day prior to
each training session and during the session the monkey
was given a liquid reward for correct fixation. After
several sessions the monkey learned to fixate the light at
various positions and the eye coil was calibrated. The
second surgery involved trephining a hole 2 cm in
diameter in the midline of the occipital area of the
monkey’s skull. A stainless steel recording chamber
(Trent Wells 3-0558) was then implanted over the hole.
Its axis lay in the midsagittal plane, tilted back from the
vertical by 20° and was positioned so that it would pass
through a point on the midline 4 mm posterior to and
2 mm above the inter-aural axis. This corresponds to a
position midway between the abducens nuclei (Smith,
Kastella & Randall, 1972).
2.2. Measurement of eye mo6ements, unit recording
and stimulation
Eye movements were recorded using the eye-coil:
magnetic-field system (Robinson, 1963). The monkey
sat in a primate chair with its head fixed in the center of
the field coils. The noise level of the system was approx-
imately 15 min of arc, and bandwidth was 0–1 kHz. An
ultra-violet mirror-galvanometer (Honeywell Visicorder
1108) and an FM tape recorder (Vetter Model B),
simultaneously recorded horizontal and vertical move-
ments of one eye, and target position, when relevant.
The goal of recording from single neurons was to
locate the abducens nuclei and identify sites for injec-
tion. Monopolar tungsten micro-electrodes were used
for single-unit extracellular recording and stimulation.
The tips were insulated with epoxylite varnish until
their impedance (at 1 kHz) was between 1 and 3 MV
for recording electrodes and about 500 kV for stimulat-
ing electrodes. The electrode was placed in a guide tube
consisting of 22 gauge tubing cut to a length between
68 and 72 mm depending on the size of the monkey’s
head. This assembly was then inserted into the brain so
that the tip of the guide tube lay approximately 6 mm
above the floor of the fourth ventricle. The electrode
was then advanced out of the guide tube, through the
cerebellum and fourth ventricle, and into the brainstem
using a Trent Wells hydraulic microdrive (3-0590).
Recordings were made at various locations to allow a
map of brainstem landmarks to be made. The two
abducens nuclei were identified by the characteristic
‘singing’ sound produced on the audio monitor. In
addition, the cells were very densely packed and all
fired at a rate proportional to ipsilateral eye position
and eye velocity. The rostro-caudal and medio-lateral
borders of these areas were delineated to make sure
that they were the abducens nuclei. A volume was then
explored 1 mm to 2 mm caudal to the caudal border of
the abducens nuclei and 1–4 mm lateral, where many
sites were found in which firing rates of cells varied
with eye movements, and stimulation produced eye
movements. This was presumably the relevant region
within the NPH-MVN and would especially include the
marginal zone (McFarland & Fuchs, 1992). Chemicals
were injected throughout these regions.
2.3. Injections
Chemicals were injected into the NPH-MVN region
via a 29 gauge metal cannula that was advanced
through a guide tube in the same manner as the elec-
trodes. Injections were made with a 10 ml Hamilton
Luer tip microsyringe controlled by a stepper motor.
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The volume of all injections was 1 ml; all were unilat-
eral in each monkey. The chemicals were mixed in a
solution of saline and Hepes buffer with a pH of 7.4.
The following chemicals were used: muscimol (Sigma),
10 mM; bicuculline (Sigma), 10 mM; strychnine
(Sigma), 100 mM; glycine (Sigma), 1 mM; kainic acid
(Sigma), 50 mM; DNQX (6,7-Dinitroquinoxoline-2,3-
dione) (Research Biochemicals), 10 mM; NMDA (N-
methyl-D-aspartic acid) (Sigma), 50 mM; APV
(2-amino-5-
phosphonovaleric acid) (Sigma), 1 mM. Before and at
various times after the injections the monkey’s random
saccades, and post-saccadic drifts in the dark, were
recorded to assess the function of the integrator. Dur-
ing these times the monkeys were kept alert by audi-
tory stimulation. Generally, the monkey’s integrator, if
affected, recovered by 2 h, so that its time constant
was at least 50% of the pre-injection value, when mon-
itoring was stopped.
2.4. Lesions and identification of injection sites
Electrolytic midline lesions were made in two mon-
keys by passing 100 mA of anodic DC current into the
brainstem for 1 min. Eye movement data were col-
lected before and after the lesions. Each monkey was
then allowed to recover for 4–5 weeks at which point
its spontaneous eye movements in the dark were
recorded again to determine what recovery had taken
place; these studies have been previously reported
(Arnold & Robinson, 1997). Shortly after the last
recordings the monkeys were perfused under deep pen-
tobarbital anesthesia with a cardiac injection of 10%
neutral formalin through the left ventricle. The brains
were blocked and 50 mm frozen sections were cut
from them in a transverse plane containing the elec-
trode tracks. Alternate sections were then stained with
cresyl violet. These sections allowed localization of
sites of injections and lesions.
2.5. Analysis of eye mo6ements
Eye movements were analyzed from the Visicorder
output by hand. We analyzed gaze-holding in darkness
after a saccade brought the eye to a new orbital posi-
tion; smooth-pursuit and vestibular eye movements
were not studied. The most common effect of the
injections was to impair gaze holding so that the eyes
drifted, with decreasing velocity, toward the center. In
these cases, the time constant of the drift was mea-
sured to provide an estimate of neural integrator func-
tion. It is a property of an exponential of time
constant t, that a tangent to it at a time t0 will
intersect the abscissa at time t0t, thus providing a
simple graphic way to estimate t. Since the variations
in t created by these experiments covered two decades
(0.2–20 s) an attempt at greater accuracy in measuring
t would not have contributed to any better interpreta-
tion. Consequently, time constants were calculated by
drawing a line tangent to the eye movement trace at a
point immediately after a saccade and taking the dif-
ference between that time and the time at which the
tangent line crossed the null position. The null posi-
tion was measured, in each case, as the position (usu-
ally near zero) at which the postsaccadic eye velocity
reversed its sign. Each time constant was calculated at
five different points on a given recording and the
average was used as the nominal value; the standard
deviation reflected variability. Injections at some sites
caused constant-velocity slow phases of nystagmus; in
these cases, the velocity when the nystagmus was most
intense, Vmax, was measured at five different points
and averaged. Sometimes, injections caused increasing-
velocity drifts (reflecting an unstable integrator); in
these cases, negative time constants were measured in
the same manner as positive time constants, except
that the tangent line intercepted the null position in
the negative direction on the time axis.
3. Results
3.1. Location of injections
Injections were made at points between 1 and 2 mm
caudal to the abducens nuclei and 1 and 4 mm lateral
to the midline. The positions of injections were deter-
mined by stereotaxic extrapolation from the physiolog-
ically identified loci of the abducens nuclei and were
corroborated by histology. Fig. 1 illustrates some of
the injection sites for muscimol (A), bicuculline (B),
and other chemicals (C). This figure in conjunction
with the coordinates given in Table 1, permits the
approximate location of all injection sites. With 41
injections in three monkeys, many overlapping, all
cannula tracks could not be identified individually,
although all were confined to the region illustrated.
Moreover, 1 ml injections will probably spread over an
effective distance of at least 90.5 mm. Although dif-
ferences were seen between different injection sites (see
below), the techniques used here were not intended to
elucidate micocircuitry but only to test more general
pharmacological localization of the neural integrator.
No overt non-oculomotor effects were noticed, ex-
cept in the three muscimol injections that made the
integrator unstable with negative time constants (indi-
cated by asterisk in Table 1). In each of these cases
the monkey put the ear ipsilateral to the injection side
down on the floor of its cage for about 1 h following
the end of the experiment.
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3.2. Muscimol (GABA agonist) injections
Ten unilateral, 1 ml injections of 10 mM muscimol
were made in the caudal pons, 1–2 mm caudal to the
abducens nuclei and 1–3 mm lateral to the midline
(Table 1). Five of these injections, between 1 and 2.5
mm lateral, resulted in a marked reduction in the time
constant of the integrator to the minimum value tmin
shown. A typical example of such injections causing the
integrator to become leaky is shown in Fig. 2. Prior to
injection (Fig. 2A), the monkey could hold eccentric
gaze steadily in darkness. The normal time constant of
centripetal eye drift for humans is approximately 20 s
(Leigh & Zee, 1999), and monkeys are comparable. The
mild downbeat nystagmus in Fig. 2A is normal in the
rhesus monkey. After the injection (Fig. 2B), the inte-
grator has become very leaky, causing gaze-evoked
nystagmus. Note, however, that there was some vari-
ability in the centripetal drift, from beat to beat; that
some individual slow phases appeared to show more
than one rate of drift; and some were almost linear (see
Section 4). After each of these five injections, the inte-
grator time constant, tmin was reduced to between 0.2
and 1.5 s (mean 0.9 s) within 5–10 min of the injection.
During a 2 h period following each injection, the
time constant slowly increased to greater than 5 s. The
time constant eventually returned to normal within a
day or two. Fig. 3 illustrates typical time courses of the
integrator time constants following these injections. The
changes in time constants followed similar trajectories
after each injection, and probably reflected the time
course of the injection diffusing away from the site.
Smaller time constants were associated with longer
recovery periods. After an injection, the null point
(estimated by noting the eye position at which post-sac-
cadic drift reversed direction) shifted, even within 1
min, up to 10° either ipsilaterally or contralaterally,
with no consistent trend. It tended to decrease toward
zero, within an hour.
In two cases, injection of muscimol created simple
nystagmus (Vmax, Table 1). The slow phases were
straight indicating a normal integrator — otherwise
they would have been curved. This is indicative of a
vestibular imbalance similar to a peripheral vestibular
lesion. Both sites were at the lateral limit (3 mm)
investigated. The constant-velocity slow phases had a
peak velocity of about 10 °:s, ipsilateral to the injection.
Finally, injection at three sites (indicated by asterisks
in Table 1) created a novel finding — they made the
neural integrator unstable. As illustrated in Fig. 4A, the
eyes drifted away from the null point with a waveform
resembling a growing exponential, which can be de-
scribed by a negative time constant. In each case the
monkey only made eye movements on one side of the
null point, the side ipsilateral to the injection.
The dependence of the results on the location of the
injection is reported in Table 1. Injections between 1.0
and 2.7 mm produced a reduction in integrator time
constant. Injections around 2.7–3.0 mm made the inte-
grator unstable (*) while more lateral injections at 3.0
mm produced nystagmus with linear slow phases. From
Fig. 1, the boundary between the production of a leaky
Fig. 1. The location of the region of the injection sites. PH, nucleus prepositus hypoglossi; MVN, medial vestibular nucleus; DVN, descending
vestibular nucleus; LVN, lateral vestibular nucleus; Y, y-group of the vestibular nucleus; SCP, superior cerebellar peduncle. The symbols represent
examples of the loci where injections were made that resulted in the following effects: filled triangle, leaky integrator (see Fig. 2B for examples);
star, unstable integrator (see Fig. 4A and B for examples); c , either an unstable integrator or constant-velocity nystagmus without affecting the
integrator; filled circles, nystagmus without affecting the integrator (see Fig. 4C),  , no effect. All slices are through a transverse section plane
tilted caudally from stereotactic vertical by 20° and 1.5 mm caudal to the abducens nuclei. (A) muscimol sites; (B) bicuculline sites; (C) sites where
NMDA, APV, kainic acid, DNQX, glycine, strychnine, or saline were injected. For clarity, not all sites are shown; many sites overlapped; Table
1 provides the lateral location of every injection site.
D.B. Arnold et al. : Vision Research 39 (1999) 4286–42954290
Table 1
Results of injections of chemical agents on gaze stabilitya
Monkey ResultAgent Location
Muscimol (GABAA receptor agonist), 10 mM
2 tmin1.090.1 s1.0 mm L
11.5 mm L tmin0.290.02 s
3 tmin1.190.1 s1.7 mm L
12.0 mm R tmin1.590.2 s
2 tmin0.890.1 s2.5 mm R
32.7 mm L tmin0.890.2 s*
2.7 mm L 3 tmin1.190.2 s*
23.0 mm R tmin1.290.2 s*
3.0 mm R 2 Vmax1391 °:s
3.0 mm R 2 Vmax891 °:s
Bicuculline (GABAA receptor antagonist), 10 mM
2 tmin4.890.6 s1.0 mm L
11.5 mm L tmin1.990.2 s
11.5 mm L tmin1.790.1 s
21.5 mm R Vmax1891 °:s
2.0 mm L 3 Vmax1191 °:s
3 Vmax1591 °:s2.7 mm L
32.7 mm L Vmax1491 °:s
2 No effect4.0 mm R
24.0 mm R No effect
NMDA, 50 mM
11.5 mm L tmin0.890.2 s
3.0 mm L 3 tmin1.590.3 s
23.0 mm R tmin0.990.1 s
APV (NMDA antagonist), 1 mM
1 tmin3.090.3 s1.5 mm L
11.5 mm L tmin3.690.3 s
3 No effect3.0 mm L
2 tmin2.890.3 s3.0 mm R
Kainic acid, 50 mM
11.5 mm L tmin0.790.1 s
32.7 mm L tmin0.590.1 s
2 tmin1.390.1 s3.0 mm R
DNQX (kainate receptor antagonist), 10 mM
11.5 mm L tmin2.090.2 s
23.0 mm R tmin1.090.2 s
3 No effect2.7 mm L
a tmin refers to the minimum time constant reached by the integra-
tor. Negative time constants, indicated by *, indicate an unstable
integrator where the eyes moved away from the center, as in Fig. 4.
Vmax is the velocity of the slow phases of constant-velocity nystag-
mus, when it was most intense. In both cases following muscimol
injection, the slow phases were ipsilateral. For the four cases follow-
ing bicuculline injection, the slow phases of Vmax were ipsilateral in
one case and contralateral in the other three. Recall from Fig. 1 that
the locations less than 1.7 mm are probably in the NPH; from 1.7 to
3.5 in the MVN; and beyond 3.5 in the DVN. All injections were on
the left (L) in Monkeys 1 and 3 and the right (R) in Monkey 2.
Variability is shown by 91 S.D. All injections were 1 ml.
were made in roughly the same area of the caudal pons
as the muscimol injections (Fig. 1B and Table 1). The
three most medial injections, all between 1.0 and 1.5
mm and probably confined to the NPH, made the
integrator leaky. The average time constant was 2.8 s.
The time constants generally were reduced less and
recovered faster than after muscimol injections (Fig. 3).
The null points stayed within 5° of the center of gaze
and the direction of the shift was inconsistent. Four
other injections from 1.5 to 2.7 mm lateral produced a
nystagmus characterized by slow phases of constant
velocity (around 15 °:s, Table 1) as illustrated in Fig.
4B. These injections were mainly in the medial half of
the MVN. Unlike the muscimol injections, the direction
of the slow phases of the nystagmus could be ipsilateral
(1 case) or contralateral (3 cases) to the side of the
injection. Two injections at 4 mm, undoubtedly in the
DVN (Fig. 1), had no effect.
3.4. NMDA and APV (NMDA receptor antagonist)
injections
Three 1 ml, 50 mM unilateral injections of NMDA
were made at locations within 3 mm of the midline
(Table 1). All three injections made the integrator
leaky. The mean tmin was 1.1 s. The time constants
exhibited a time course similar to muscimol, but with a
slightly faster recovery (Fig. 3). Four unilateral 1 ml
injections of 1 mM APV were made. As can be seen in
Table 1, three of the four resulted in a leaky integrator,
while the fourth produced no effect. The minimum time
constant (mean 3.1 s) as well as the time course of
recovery were virtually the same as in the case of
injections of bicuculline (Fig. 3). These injections
ranged from the marginal zone (NPH-MVN boundary)
to lateral MVN but laterality seemed not to make a
difference.
3.5. Kainic acid and DNQX (kainate receptor
antagonist) injections
Three 1 ml injections of 50 mM kainic acid were made
within 3 mm of the midline (Table 1). All three injec-
tions produced a leaky integrator. The mean time con-
stant was 0.8 s, the lowest of all averages. Three
unilateral, 1 ml injections of 10 mM DNQX were made
within 3 mm of the midline (Table 1). Two out of the
three injections produced a leaky integrator, while the
third had no effect.
3.6. Glycine and strychnine (glycine antagonist)
Three unilateral, 1 ml injections of 1 mM glycine (one
in each monkey) were made within 1.5–3 mm of the
and an unstable integrator is near the medial-lateral
center of the MVN at this level.
3.3. Bicuculline (GABA antagonist) injections
Nine unilateral 1 ml injections of 10 mM bicuculline
D.B. Arnold et al. : Vision Research 39 (1999) 4286–4295 4291
midline. In each case there was no discernible effect on
eye movements. Three unilateral, 1 ml injections of 100
mM strychnine were made within 1.5–3 mm of the
midline (at the locations similar to those in Fig. 1C). No
changes in eye movements were apparent after these
injections. These results suggest that glycine is not a
major factor in integrator connections.
3.7. Controls
In each of the three monkeys a 1 ml injection of
normal saline was made within 3 mm of the midline.
These produced no discernible change in eye
movements.
4. Discussion
The main finding of this study is that injection of
chemicals with either agonist or antagonist effects on
GABA, glutamate, or kainate receptors in the NPH-
MVN region interferes with the ability to hold the eyes
steadily at an eccentric position in the orbits. Glyciner-
gic agents had no effect. The commonest effect of
pharmacological inactivation was to make the neural
integrator for eye movements ‘leaky’, causing cen-
tripetal drifts of the eyes and gaze-evoked nystagmus.
At some injection sites, either bicuculline or muscimol
caused nystagmus with linear slow phases. Several of
these effects have been previously reported for indiv-
Fig. 2. An example of eye movements associated with an injection that caused the neural integrator to become leaky. (A) Prior to a 1 ml injection
of 10 mM muscimol. (B) Following the injection, at the time of maximum effect. In (A), the trained monkey, in darkness, is searching for the
targets normally visible at 0 and 20° right. Note the normal horizontal gaze-holding. The mild down-beating nystagmus is normal for the rhesus
monkey. In (B) the integrator has become very leaky, creating gaze-evoked nystagmus. See text for discussion. In this and other figures, U, D,
R, and L indicate up, down, right and left, respectively.
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Fig. 3. Representative time courses of the neural integrator time constant following injections of each of the chemical agents employed in this
study. Muscimol, NMDA, DNQX, and kainic acid all decreased the time constant below 2 s, whereas Bicuculline and APV had milder effects.
Smaller time constants were associated with longer recovery periods. For minimum values of the time constant measured for all injections, see
Table 1.
idual agents (Cannon & Robinson, 1987; Cheron &
Godaux, 1987; Straube et al., 1991; Mettens et al.,
1994a, b). A novel finding was that muscimol injections
into the center of the MVN sometimes caused the eyes
to drift away from the central position with increasing-
velocity waveforms, suggesting that the neural integra-
tor had become unstable. A similar effects has been
previously reported by Straube et al. (1991), after injec-
tion of bicuculline into the vestibular nuclei. How can
these results — in which agonist or antagonist of
specific transmitter receptors had similar effects — be
explained?
4.1. Interpretation of the effects of pharmacological
inacti6ation
Present evidence suggests that the neural integration
of oculomotor signals depends on a distributed network
of neurons; in the horizontal plane, the NPH-MVN
region is critical (Arnold & Robinson, 1997). Pharma-
cological agents may prevent the constituent neurons of
this network from modulating their discharge in re-
sponse to inputs from other neurons; this would cause
the integrator to become leaky. This effect would be
expected both for agents such as muscimol, which
hyperpolarizes cells (and drives them into cutoff) and
drugs such as bicuculline, which depolarize cells (and
drives their discharge rates into saturation).
A suggested mechanism whereby the neural integra-
tor could become unstable is that its constituent neu-
rons remain functional, but that the feedback control of
them — by the cerebellum — be disrupted (Kamath &
Keller, 1976; Zee, Leigh & Mathieu-Millaire, 1980).
Experimentally, such instability is reported following
injection of either the GABAA agonist, muscimol (this
study) or the GABAA antagonist bicuculline (Straube et
al., 1991) into that portion of the MVN which receives
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floccular afferents and lies lateral to the marginal zone
(Bu¨ttner-Ennever, 1992). Floccular Purkinje cells are
know to be GABAergic (Mugnaini & Oertel, 1985) and
so it seems possible that inactivating their projections to
neurons in MVN might be responsible for instability of
the neural integrator. Perhaps of relevance to this issue
is that acquired nystagmus with increasing velocity
waveforms is reported in patients with cerebellar lesions
(Zee et al., 1980; Barton & Sharpe, 1993).
Finally, a finding that deserves some explanation is
that, after some injections with muscimol (for example,
Fig. 2B), slow phases of nystagmus appeared to show
more than one time constant of drift, some appearing
to be almost linear. This phenomenon has been previ-
ously documented (see, for example, Fig. 6 from the
study by Straube et al., 1991). It has been suggested
(prompted by clinical observations) that centripetal
drifts with more than one time constant could be due to
non-linearities within the neural integrator (Abel, Del-
l’Osso & Daroff, 1978); this seems likely in the present
study, since microinjections only inactivated part of the
network of cells contributing to normal gaze-holding.
In those cases when slow phases of nystagmus were
uniformly linear (especially following bicuculline injec-
tion as in Fig. 4C), a vestibular imbalance has been
postulated (Straube et al., 1991).
Fig. 4. Examples of injections that caused nystagmus with either increasing-velocity (A, B) or linear (C) slow phases (note different scales on each
panel). (A) Effects of 1 ml injection of 10 mM muscimol in Monkey 3 injected 2.7 mm lateral to midline. (B) Effects of 1 ml injection of 10 mM
muscimol in Monkey 2 injected 3 mm lateral to midline. Note that the slow-phase drift away from the null point approximates an increasing
exponential, indicating an unstable integrator. (C) Example of an injection causing nystagmus without integrator failure. The effect was produced
by 1 ml injection of 10 mM bicuculline in Monkey 3. The record shows spontaneous nystagmus, in darkness, that has linear slow phases with a
velocity of 15 °:s.
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4.2. Implications of the present study for treatment of
nystagmus
Abnormal eye movements, such as pathological nys-
tagmus, impair vision by causing excessive motion of
images on the retina. Gaze-evoked nystagmus may
interfere with clear vision during attempted eccentric
gaze. Other disorders — such as acquired pendular
nystagmus — cause ocular oscillations when the eyes
are close to the central position and lead to trouble-
some visual symptoms. The initial reports that
GABAergic projections contributed to the neural inte-
grator (Straube et al., 1991; Mettens et al., 1994a)
prompted a double-blind study to evaluate two
GABAergic agents, baclofen and gabapentin (Aver-
buch-Heller, Tusa, Fuhry, Rottach, Ganser, Heide et
al., 1997). The latter agent was shown to be an effective
treatment in some patients with acquired pendular nys-
tagmus. Another open-label study showed that meman-
tine, a drug with glutamine-antagonist effects, was also
effective in suppressing acquired pendular nystagmus
(Starck, Albrecht, Straube & Dieterich, 1997). The re-
sults of the present study strengthen the rationale for
evaluating drugs that influence either GABA or glu-
tamine mechanisms as treatment for pathological
nystagmus.
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